FIGURE

Figure 2

ID

ZDB-FIG-210727-37

Publication

Okuda et al., 2021 - 3,4-Difluorobenzocurcumin Inhibits Vegfc-Vegfr3-Erk Signalling to Block Developmental Lymphangiogenesis in Zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Figure 2

3,4-Difluorobenzocurcumin treatment inhibits lymphatic migration. (A) Schematic representation of the treatment schedule for larvae in images (B–E’). (B–E’) Lateral confocal images of 3 (1 days post-treatment (dpt), B,B’,D,D’) and 4 (2 dpt, C,C’,E,E’) dpf Tg(fli1a:nEGFP);Tg(-5.2lyve1b:DsRed2) larvae treated from 2.5 dpf with either 0.1% DMSO (B–C’) or 2.5 μM 3,4-Difluorobenzocurcumin (CDF, D-E’). LEC migration is stalled in larvae treated with CDF. Images (B’–E’) represent the Tg(-5.2lyve1b:DsRed2) expression of images (B–E). (F–H) Quantification of parachordal LECs (PL, F), thoracic duct (TD, G) or dorsal longitudinal lymphatic vessel (DLLV, H) nuclei per somite in Tg(fli1a:nEGFP);Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO or 2.5 μM CDF at indicated timepoints (n = 20 embryos/larvae). Statistical test: Kruskal-Wallis test was conducted for graph F and Mann-Whitney test were conducted for graphs G and H. p ≤ 0.001 (***), p ≤ 0.05 (*), n.s. indicates not significant. Scale bars: 100 μm.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceuticals (Basel)